Dave lost 97% of its value before a 1-for-32 reverse split. The fintech app has surged back, but it shows that a quick IPO ramp can make for a bumpy ride on Wall Street.
Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.
Cooper Cos. could get a pop from the sale of a surgical unit. What activists are up to.
The gain shows the strength of the company’s railroad, energy and manufacturing, service, and retailing unit.
Long Read
A resilient consumer and product “newness” are driving up retail stocks. Dana Telsey of Telsey Advisory Group shares her favorite names.
International expansion and surging profitability help make Remitly Global stock a buy.
Long Read
Passing the Clarity Act would be an important step toward creating a regulated market structure that is safe for investors, Samara Epstein Cohen writes.
3 minute read
Kevin Warsh’s restraint on issuing guidance is exposing deeper structural cracks at the central bank, Jai Kedia writes.
4 minute read
The Federal Reserve is undergoing its most significant institutional reform of the modern era. One critical area is being neglected, Amit Seru and Mickey D. Levy write.
AI hyperscalers are taking on tons of debt just as the macroeconomy is starting to look gloomier, Brij Khurana writes.
August 10, 2026
The state’s light regulation and low taxes are luring dozens of big companies. It’s also setting up a water crisis and a “race to the bottom” in shareholder protections.
Long Read
The Trump administration’s contradictory AI policies undermine its goal to beat China in the AI race, Sam Bresnick writes.
4 minute read
The U.S. needs legislation to stop members of Congress from getting rich over the course of decades in office, Brian Hamilton writes.
4 minute read
GameStop’s bid to buy eBay was loudly rejected by the company’s board. Ryan Cohen remains committed to the deal and says it will ultimately be up to shareholders.
Long Read
The diesel engine maker is no stranger to boom-bust business cycles.
4 minute read
“This is like the best of all worlds for retirees,” says one investment specialist. Thank rising yields on bonds and strong stock performance.
3 minute read
A Roth conversion is often proposed without the nuanced guidance needed to determine whether it is truly the right fit, this financial advisor argues.
Long Read
Here is our weekly roundup of the most-read articles at Barron’s Advisor.
2 minute read
The firm’s newest team is led by industry veteran Sidney Jones.
2 minute read
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| MasterBeef Group (MB) | 137.87% | $8.92 |
| Avita Medical Inc. (RCEL) | 63.58% | $7.77 |
| INNOVATE Corp. (VATE) | 63.43% | $12.11 |
| Gen Digital Inc. Rt (GENVR) | 55.73% | $3.94 |
| Jinxin Technology Holding Co. ADR (NAMI) | 51.55% | $4.41 |